Anti-Müllerian hormone receptor defect

Area of Science:

• Endocrinology
• Developmental Biology
• Genetics

Background:

• Anti-Müllerian hormone (AMH) is crucial for male sexual differentiation, regulating Müllerian duct regression.
• AMH functions via a signaling pathway involving specific type II and shared type I serine/threonine kinase receptors.
• Persistent Müllerian duct syndrome (PMDS) is a rare disorder where males retain Müllerian duct derivatives.

Purpose of the Study:

• To investigate the genetic basis of Persistent Müllerian duct syndrome.
• To correlate serum AMH levels with specific gene mutations in PMDS patients.

Main Methods:

• Genetic analysis of AMH and AMH receptor type II genes in PMDS patients.
• Measurement of serum AMH levels in affected individuals.

Main Results:

• Mutations in AMH or AMH receptor type II genes account for 84% of PMDS cases.
• Patients with AMH gene mutations exhibit low or undetectable serum AMH.
• Patients with AMH receptor type II mutations have normal serum AMH levels for age.

Conclusions:

• Mutations in AMH pathway genes are the primary cause of PMDS.
• Serum AMH levels serve as a diagnostic marker to distinguish between AMH and AMH receptor type II mutations in PMDS.
• The etiology of PMDS remains unknown in 14% of cases.